Showing 6371-6380 of 19367 results for "".
Minimal Disease Activity: A Practical Target in Psoriatic Arthritis
https://reachmd.com/programs/living-rheum/minimal-disease-activity-a-practical-target-in-psoriatic-arthritis/56787/Minimal disease activity offers a practical, patient-centered target for managing psoriatic arthritis across its many clinical domains. Hear Dr. Laura Coates explain how this approach can help clinicians assess disease control and tailor treatment decisions in everyday practice. Dr. Coates is a NIHRMeasuring What Matters in Psoriatic Arthritis
https://reachmd.com/programs/living-rheum/measuring-what-matters-in-psoriatic-arthritis/56349/Measuring outcomes in psoriatic arthritis is complex, because the disease affects multiple domains and varies widely between patients. As a result, capturing both clinical disease activity and the real-world impact on patients’ quality of life is essential for guiding care. Tune in to hear Dr. LauraAligning Patient and Physician Perspectives in Psoriatic Arthritis
https://reachmd.com/programs/living-rheum/aligning-patient-and-physician-perspectives-in-psoriatic-arthritis/56879/Balancing patient and physician-reported outcomes in psoriatic arthritis is essential, especially because perceptions of disease control often differ. In this episode, Dr. Laura Coates discusses how addressing this disconnect can improve communication, guide holistic care, and enhance patient outcomFrom Evidence to Action: Lessons from the COVID-19 Response
https://reachmd.com/programs/clinicians-roundtable/evidence-action-covid-19-response-lessons/48836/The COVID-19 pandemic revealed the complexity of delivering care when scientific knowledge is incomplete and continually evolving. Hear from Dr. Darilyn Moyer, Executive Vice President and Chief Executive Officer of the American College of Physicians, as she shares insights on translating emerging sFatty Acid Profiles May Be Linked to PAH Risk
https://reachmd.com/programs/Audioabstracts/fatty-acid-profiles-may-be-linked-to-pah-risk/56328/Emerging evidence suggests circulating fatty acid profiles may influence the risk and timing of pulmonary arterial hypertension (PAH), with data from a large prospective UK Biobank study highlighting inverse associations between multiple fatty acids and PAH risk. Join Ryan Quigley as he discusses thErgonomic Strategies for Successful Hair Transplant Procedures
https://reachmd.com/programs/dermconsult/ergonomic-strategies-hair-transplant-procedure/49025/Lengthy hair transplant procedures place significant physical demands on patients, physicians, and staff, making ergonomics a critical part of success. Dr. Marc Avram outlines practical, real-world strategies to improve positioning, workflow, and the procedural environment to enhance comfortParkinson’s Research in Focus: Translating Science Into Clinical Progress
https://reachmd.com/programs/neurofrontiers/parkinsons-research-clinical-progress/48727/Translational research is reshaping the way we understand, detect, and manage Parkinson’s disease. To learn more about how current research efforts are uncovering early biomarkers and redefining intervention strategies, Dr. Jerome Lisk sits down with Dr. Michael Salvatore and Dr. Vicki Nejtek-SalvatDietary Guidance in Psoriasis: Evidence-Based Supportive Strategies
https://reachmd.com/programs/frontlines-psoriasis/dietary-guidance-psoriasis-supportive-strategies/39951/Flare patterns, patient concerns, and growing research have brought diet to the forefront of psoriasis care. Tune in as Dr. Peter Lio reviews the strongest evidence behind weight management, gluten sensitivity, and anti-inflammatory nutrition, offering clarity on how diet can support—though not replHow does chronic AD histopathology evolve from spongiosis-dominant lesions to lichenified, fibrotic plaques?
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/how-does-chronic-ad-histopathology-evolve-from-spongiosis-dominant-lesions-to-lichenified-fibrotic-plaques/48772/Christopher Bunick, MD, FAAD, discusses the roles of the six major cytokines that drive atopic dermatitis pathophysiology: IL-4, IL-13, IL-31, TSLP, IL-22, and IFN-γ.Reshaping Dialysis Care: How New Payment Models Focus on Quality and Outcomes
https://reachmd.com/programs/clinicians-roundtable/reshaping-dialysis-care-how-new-payment-models-focus-on-quality-and-outcomes/37223/As kidney care moves beyond volume-based reimbursement, models like Kidney Care Choices are driving meaningful change by prioritizing clinical outcomes, home dialysis starts, and transplant access. Here to discuss how these policy shifts have advanced value-based care and why sustained investment an